Fig. 1 · Structure
Documents & Downloads
Ro 43-5054
Glycoprotein IIb-IIIa Receptor Antagonist
Ro 43-5054 is a glycoprotein IIb-IIIa receptor antagonist that inhibits platelet aggregation. Its primary mechanism involves blocking the binding of fibrinogen and other ligands to the glycoprotein receptor, thereby reducing thrombus formation. This compound is utilized in research focused on thrombolytic therapy and the subsequent risk of early reocclusion, aiding in the investigation of cardiovascular disorders and therapeutic interventions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 138107-58-1 |
| Applications | Glycoprotein IIb-IIIa Receptor Antagonist |
| Formula | C24H27N5O7 |
| Molecular Weight | 497.50 |
| SMILES | OC([C@H](CC1=CC=CC=C1)NC([C@H](CC(O)=O)NC(CCNC(C2=CC=C(C=C2)C(N)=N)=O)=O)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.